Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain.
Guanglin LuoLing ChenAmy EastonAmy NewtonClotilde BourinEric ShieldsKathy MosureMatthew G SoarsRonald J KnoxMichele MatchettRick L PieschlDebra J Post-MunsonShuya WangJames HerringtonJohn GraefKimberly NewberryDigavalli V SivaraoArun SenapatiLinda J BristowNicholas A MeanwellLorin A ThompsonCarolyn DzierbaPublished in: Journal of medicinal chemistry (2019)
3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complete Freund's adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, respectively, following intraperitoneal (IP) doses of 30 mg/kg. The observed efficacy could be correlated with the mouse dorsal root ganglion exposure and NaV1.7 potency associated with 29.